Literature DB >> 6086800

Corticotrophin-releasing factor--mediated adrenocorticotrophin release from rat anterior pituitary cells is potentiated by C-terminal gastrin-releasing peptide.

A C Hale, J Price, J F Ackland, I Doniach, S Ratter, G M Besser, L H Rees.   

Abstract

The remission of Cushing's syndrome following surgical removal of a tumour containing bombesin-like immunoreactivity (BLI), but insignificant levels of ACTH, is described. However, an acid extract of the tumour tissue caused the release of ACTH from isolated rat anterior pituitary cells in vitro. These observations led to an investigation of the effects of synthetic C-terminal gastrin-releasing peptide (GRP(14-27] on ACTH release from isolated rat anterior pituitary cells. GRP(14-27) (10-1000 ng/ml) directly stimulated the release of ACTH in vitro, whereas lower doses (10-1000 pg/ml), ineffective themselves in eliciting ACTH release, potentiated the CRF-mediated in-vitro release of ACTH.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086800     DOI: 10.1677/joe.0.102r001

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  2 in total

1.  An immunoreactive peptide in milk contains bombesin-like bioactivity.

Authors:  L H Lazarus; G Gaudino; W E Wilson; V Erspamer
Journal:  Experientia       Date:  1986-07-15

2.  Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat.

Authors:  Christine Mountney; Hymie Anisman; Zul Merali
Journal:  Psychopharmacology (Berl)       Date:  2008-06-18       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.